These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2976347)

  • 1. [Changes in metabolic control after interruption of oral hypoglycemic agents in type II diabetic patients with secondary failure during combined therapy].
    De Mattia G; Laurenti O; Tullo MG; Ventura C; Albi F
    Clin Ter; 1988 Oct; 127(2):119-22. PubMed ID: 2976347
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of combination therapy with insulin and oral hypoglycemic agents in patients with type II diabetes during a 1-year period.
    Mozersky RP; Patel H; Bahl VK; Bahl S; Mook W
    J Am Osteopath Assoc; 1996 Jun; 96(6):346-51. PubMed ID: 8690621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Failure of oral hypoglycemic agents: clinical experiences in 20 years' follow-up].
    Aylwin CG; López G; García de los Riós M; Vial T; Pinto JL; Ojeda A; Orellana JL
    Rev Med Chil; 1988 Aug; 116(8):729-35. PubMed ID: 3255124
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin and oral hypoglycemic agents should not be used in combination in the treatment of type 2 diabetes.
    Westphal SA; Palumbo PJ
    Arch Intern Med; 2003 Aug 11-25; 163(15):1783-5; discussion 1785. PubMed ID: 12912711
    [No Abstract]   [Full Text] [Related]  

  • 7. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
    Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy with oral antidiabetic drugs].
    Kautzky-Willer A; Lechleitner M; Pieber TR; Prager R; Roden M; Wascher TC; Weitgasser R
    Acta Med Austriaca; 2004; 31(5):162-3. PubMed ID: 15747987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary combined oral antidiabetic therapy in type-2 diabetes mellitus].
    Winkler G; Baranyi E
    Orv Hetil; 2002 Oct; 143(43):2441-7. PubMed ID: 12455146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.
    Jaber LA; Ducharme MP; Edwards DJ; Slaughter RL; Grunberger G
    Pharmacotherapy; 1996; 16(5):760-8. PubMed ID: 8888072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2008 resource guide. Type 2 drugs. There are now six classes of diabetes pills and several combination oral meds. Each has a different way of helping you control your diabetes.
    McCarren M
    Diabetes Forecast; 2008 Jan; 61(1):RG7-9. PubMed ID: 18290287
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oral antidiabetic agents for the general practitioner].
    Siegmund T
    MMW Fortschr Med; 2009 Apr; 151(14):86, 88-91; quiz 92. PubMed ID: 19504847
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diabetes mellitus type II: when convert to insulin?].
    Bianda TL; Spinas GA
    Praxis (Bern 1994); 1997 Sep; 86(38):1453-7. PubMed ID: 9381045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology and treatment of patients with type 2 diabetes exhibiting failure to oral drugs.
    Efendic S; Alvarsson M; Brismar K; Wagner H
    Acta Physiol (Oxf); 2008 Jan; 192(1):117-25. PubMed ID: 18171434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renewal of oral therapy for diabetes mellitus after secondary failure].
    Guberman D
    Harefuah; 1989 Nov; 117(9):240-1. PubMed ID: 2693275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin plus glyburide combination as therapy in failure to monotherapy in type 2 diabetic patients: one month follow-up.
    Medina Santillán R; Reyes-García G; Mateos-García E
    Proc West Pharmacol Soc; 2002; 45():139-40. PubMed ID: 12434559
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral spray insulin in treatment of type 2 diabetes: a comparison of efficacy of the oral spray insulin (Oralin) with subcutaneous (SC) insulin injection, a proof of concept study.
    Guevara-Aguirre J; Guevara M; Saavedra J; Mihic M; Modi P
    Diabetes Metab Res Rev; 2004; 20(6):472-8. PubMed ID: 15386822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes.
    Albareda M; Rigla M; Rodríguez-Espinosa J; Caballero A; Chico A; Cabezas R; Carreras G; Pérez A
    Diabetes Res Clin Pract; 2005 Jun; 68(3):202-6. PubMed ID: 15936461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overnight CSII as supplement to oral antidiabetic drugs in type 2 diabetes.
    Parkner T; Møller MK; Chen JW; Laursen T; Jørgensen C; Smedegaard JS; Lauritzen T; Christiansen JS
    Diabetes Obes Metab; 2008 Jul; 10(7):556-63. PubMed ID: 17593233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.